Bitcoin halving
What does that mean?
$2.78T
Total marketcap
$99.31B
Total volume
BTC 49.54%     ETH 15.28%
Dominance

Pfizer Inc. PFE.VI Stock

25.8 EUR {{ price }} 0.194172% {{change_pct}}%
COUNTRY
Austria
Exchange
Vienna
Market Cap
146.09B EUR
LOW - HIGH [24H]
25.6 - 26.25 EUR
VOLUME [24H]
520 EUR
{{ volume }}
P/E Ratio
75.88
Earnings per share
0.34 EUR

Pfizer Inc. Price Chart

Pfizer Inc. PFE.VI Financial and Trading Overview

Pfizer Inc. stock price 25.8 EUR
Previous Close 36.3 EUR
Open 36.3 EUR
Bid 36.05 EUR x 0
Ask 36.65 EUR x 0
Day's Range 36.3 - 36.3 EUR
52 Week Range 33.8 - 52.9 EUR
Volume 0 EUR
Avg. Volume 21 EUR
Market Cap 204.92B EUR
Beta (5Y Monthly) 0.589084
PE Ratio (TTM) 7.8401723
EPS (TTM) 0.34 EUR
Forward Dividend & Yield 1.52 (4.07%)
Ex-Dividend Date May 11, 2023
1y Target Est N/A

PFE.VI Valuation Measures

Enterprise Value 223.08B EUR
Trailing P/E 7.8401723
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 2.2046535
Price/Book (mrq) 2.0294068
Enterprise Value/Revenue 2.4
Enterprise Value/EBITDA 5.49

Trading Information

Pfizer Inc. Stock Price History

Beta (5Y Monthly) 0.589084
52-Week Change -18.82%
S&P500 52-Week Change 20.43%
52 Week High 52.9 EUR
52 Week Low 33.8 EUR
50-Day Moving Average 35.9 EUR
200-Day Moving Average 41.96 EUR

PFE.VI Share Statistics

Avg. Volume (3 month) 21 EUR
Avg. Daily Volume (10-Days) 12 EUR
Shares Outstanding 5.65B
Float 5.64B
Short Ratio N/A
% Held by Insiders 0.034%
% Held by Institutions 70.67%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.61
Trailing Annual Dividend Yield 4.43%
5 Year Average Dividend Yield 354.00%
Payout Ratio 0.3176
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) April 2, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 31.25%
Operating Margin (ttm) 37.99%
Gross Margin 68.93%
EBITDA Margin 43.71%

Management Effectiveness

Return on Assets (ttm) 11.63%
Return on Equity (ttm) 31.61%

Income Statement

Revenue (ttm) 92.95B EUR
Revenue Per Share (ttm) 16.56 EUR
Quarterly Revenue Growth (yoy) -28.79%
Gross Profit (ttm) 66.23B EUR
EBITDA 40.64B EUR
Net Income Avi to Common (ttm) 29.03B EUR
Diluted EPS (ttm) 4.63
Quarterly Earnings Growth (yoy) -29.50%

Balance Sheet

Total Cash (mrq) 19.97B EUR
Total Cash Per Share (mrq) 3.54 EUR
Total Debt (mrq) 36.17B EUR
Total Debt/Equity (mrq) 35.72 EUR
Current Ratio (mrq) 1.37
Book Value Per Share (mrq) 17.887

Cash Flow Statement

Operating Cash Flow (ttm) 23.94B EUR
Levered Free Cash Flow (ttm) 17.96B EUR

Profile of Pfizer Inc.

Country Austria
State NY
City New York
Address 66 Hudson Boulevard East
ZIP 10001-2192
Phone 212 733 2323
Website https://www.pfizer.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 83000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Q&A For Pfizer Inc. Stock

What is a current PFE.VI stock price?

Pfizer Inc. PFE.VI stock price today per share is 25.8 EUR.

How to purchase Pfizer Inc. stock?

You can buy PFE.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pfizer Inc.?

The stock symbol or ticker of Pfizer Inc. is PFE.VI.

Which industry does the Pfizer Inc. company belong to?

The Pfizer Inc. industry is Drug Manufacturers-General.

How many shares does Pfizer Inc. have in circulation?

The max supply of Pfizer Inc. shares is 5.66B.

What is Pfizer Inc. Price to Earnings Ratio (PE Ratio)?

Pfizer Inc. PE Ratio is 75.88235000 now.

What was Pfizer Inc. earnings per share over the trailing 12 months (TTM)?

Pfizer Inc. EPS is 0.34 EUR over the trailing 12 months.

Which sector does the Pfizer Inc. company belong to?

The Pfizer Inc. sector is Healthcare.